-
TLSI Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
TriSalus Life Sciences (TLSI)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 11.64 mm | 11.64 mm | 11.64 mm | 11.64 mm | 11.64 mm | 11.64 mm |
Cash burn (monthly) | 1.73 mm | 832.92 k | 2.91 mm | 5.45 mm | 3.62 mm | 3.65 mm |
Cash used (since last report) | 8.81 mm | 4.24 mm | 14.82 mm | 27.74 mm | 18.39 mm | 18.56 mm |
Cash remaining | 2.83 mm | 7.40 mm | -3.18 mm | -16.11 mm | -6.76 mm | -6.92 mm |
Runway (months of cash) | 1.6 | 8.9 | -1.1 | -3.0 | -1.9 | -1.9 |
13F holders | Current |
---|---|
Total holders | 32 |
Opened positions | 22 |
Closed positions | 2 |
Increased positions | 2 |
Reduced positions | 1 |
13F shares | Current |
---|---|
Total value | 7.07 bn |
Total shares | 14.47 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Equity AB Frankenius | 6.40 mm | $0.00 |
Lombard International Assurance | 1.98 mm | $8.28 mm |
Unique Diamond Investments | 1.55 mm | $0.00 |
Christopher C Dewey | 1.52 mm | $0.00 |
Mats Wahlstrom | 1.37 mm | $0.00 |
Wealthcare Advisory Partners | 643.74 k | $2.97 bn |
Vanguard | 416.14 k | $1.92 bn |
Geode Capital Management | 200.43 k | $924.19 mm |
HRT Financial | 43.83 k | $100.00 k |
Exos Asset Management | 38.60 k | $177.96 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
18 Feb 25 | Jodi Devlin | Common Stock | Grant | Acquire A | No | No | 0 | 5,272 | 0.00 | 33,397 |
18 Feb 25 | Szela Mary T | Common Stock | Grant | Acquire A | No | No | 0 | 21,089 | 0.00 | 465,348 |
18 Feb 25 | Bryan F. Cox | Common Stock | Grant | Acquire A | No | No | 0 | 11,450 | 0.00 | 108,457 |
18 Feb 25 | Richard Marshak | Common Stock | Grant | Acquire A | No | No | 0 | 7,644 | 0.00 | 54,270 |
18 Feb 25 | Jennifer Stevens | Common Stock | Grant | Acquire A | No | No | 0 | 14,481 | 0.00 | 57,889 |